Table 1 Demographic, clinical and laboratory characteristics of patients with early rheumatoid arthritis at baseline, and of patients with longstanding rheumatoid arthritis at the moment of the analysis
CharacteristicsPatients with ERA(n = 100)LSRA(n = 114)
Female, n (%)75 (75.0)97 (85.1)
Age (years), mean (SD)54.9 (13.8)57.1 (13.6)
Disease duration (years), mean (SD)0.6 (0.3)13.7 (10.0)
Tender joint count, mean (SD)15.5 (10.1)8.3 (8.9)
Swollen joint count, mean (SD)11.4 (8.7)5.3 (6.2)
Anti-CCP (U/ml), mean (SD) {median}48.6 (63.4) {13.9}49.6 (91.3) {17.0}
Anti-CCP ⩾5 U/ml, n (%)65 (65.0)78 (68.4)
IgM RF (U/ml), mean (SD) {median}61.6 (98.6) {27.1}46.5 (78.8) {13.4}
IgM RF ⩾20 U/ml, n (%)54 (54.0)47 (41.2)
IgA RF (U/ml), mean (SD) {median}75.6 (149.9) {14.8}52.0 (122.2) {10.2}
IgA RF ⩾20 U/ml, n (%)43 (43.0)33 (28.9)
CRP (mg/l), mean (SD)24.1 (30.6)6.9 (11.9)
ESR (mm/1st h), mean (SD)40.6 (24.6)23.7 (19.5)
DAS44, mean (SD)3.9 (1.4)2.7 (1.4)
HAQ, mean (SD)1.24 (0.78)1.05 (0.80)
  • anti-CCP, anti-cyclic citrullinated protein; CRP, C-reactive protein; DAS, disease activity score; ERA, early rheumatoid arthritis; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire; LSRA, longstanding rheumatoid arthritis; RF, rheumatoid factor.